making the most out of medicines
MAECON works at the University Medical Center Groningen (UMCG) and/or the University of Groningen (UG). The members are independent senior researchers and represent a wide range of sub-specialisms related to medication adherence.
MAECON currently has 13 members, who work at the University Medical Center Groningen (UMCG) and/or the University of Groningen (UG). These members are independent senior researchers and represent a wide range of sub-specialisms related to medication adherence.
‘Drugs don’t work in people who don’t take them’ (a quote attributed to C. Everett Coop, former US Surgeon General). The ageing society is a key contributor to a steady increase in the number of patients with a chronic disease and multimorbidity. This requires a multifaceted response, which often involves lifetime medication use.
Most medications have proven their efficacy in large randomised clinical trials. However, in practice, the effectiveness of medications often turns out to be much lower. This is largely due to poor medication adherence. Depending on the disease and definitions used, medication non-adherence is found in up to 50% of patients who are using chronic medication. It is important to note that, in the European Union alone, medication non-adherence is associated with an estimated 200,000 deaths and €125 billion of potentially preventable direct costs, such as hospital admissions and drug waste, as well as potentially preventable indirect costs, such as productivity loss at work.
In the last decades, there has been little improvement in medication adherence. Unfortunately, this applies to the whole range of chronic diseases. The fragmentation of medication adherence research, poor awareness among stakeholders, lack of effective and personalized strategies, and poor implementation and incentives in daily clinical practice are some of the key factors contributing to the poor results in terms of progress and change. To achieve real progress in medication adherence, make better use of existing medications, and ultimately foster healthy ageing of societies, the time has come to unite all forces into one adherence expertise centre that serves as a knowledge hub as well as an implementation platform.
Discover our services
“Drugs don’t work in people who don’t take them” - C. Everett Coop
About UMCG Research
Innovative and high-quality research conducted at the UMCG is understanding the mechanisms underlying diseases, developing new diagnostics and treatments, and building a network for sustainable health.
The UMCG adherence researchers are pioneers in research who work on relevant research topics and are provided with a broad range of top-notch research facilities. The groundbreaking work of leading national and international researchers makes the UMCG a pioneering centre for medical research.